Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C10H12O |
| Molecular Weight | 148.2017 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1CCC2=CC=CC=C2C1
InChI
InChIKey=JWQYZECMEPOAPF-UHFFFAOYSA-N
InChI=1S/C10H12O/c11-10-6-5-8-3-1-2-4-9(8)7-10/h1-4,10-11H,5-7H2
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers. | 2013-02-25 |
|
| Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: implications for the pharmacological effects of inhaled corticosteroids. | 2011-05-30 |
|
| Engineering and Applications of fungal laccases for organic synthesis. | 2008-11-20 |
|
| Radiolytic degradation of Acid Orange 7: a mechanistic study. | 2005-11 |
|
| Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone. | 2003-02-01 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6AE2V413JI
Created by
admin on Mon Mar 31 22:13:59 GMT 2025 , Edited by admin on Mon Mar 31 22:13:59 GMT 2025
|
PRIMARY | |||
|
5669
Created by
admin on Mon Mar 31 22:13:59 GMT 2025 , Edited by admin on Mon Mar 31 22:13:59 GMT 2025
|
PRIMARY | |||
|
m10639
Created by
admin on Mon Mar 31 22:13:59 GMT 2025 , Edited by admin on Mon Mar 31 22:13:59 GMT 2025
|
PRIMARY | Merck Index | ||
|
10747
Created by
admin on Mon Mar 31 22:13:59 GMT 2025 , Edited by admin on Mon Mar 31 22:13:59 GMT 2025
|
PRIMARY | |||
|
44875
Created by
admin on Mon Mar 31 22:13:59 GMT 2025 , Edited by admin on Mon Mar 31 22:13:59 GMT 2025
|
PRIMARY | |||
|
5679
Created by
admin on Mon Mar 31 22:13:59 GMT 2025 , Edited by admin on Mon Mar 31 22:13:59 GMT 2025
|
PRIMARY | |||
|
208-497-8
Created by
admin on Mon Mar 31 22:13:59 GMT 2025 , Edited by admin on Mon Mar 31 22:13:59 GMT 2025
|
PRIMARY | |||
|
DTXSID60870589
Created by
admin on Mon Mar 31 22:13:59 GMT 2025 , Edited by admin on Mon Mar 31 22:13:59 GMT 2025
|
PRIMARY | |||
|
530-91-6
Created by
admin on Mon Mar 31 22:13:59 GMT 2025 , Edited by admin on Mon Mar 31 22:13:59 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD